FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 99 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q1 2022. The put-call ratio across all filers is 6.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,467,000 | +232.1% | 274,027 | +14.7% | 0.00% | +100.0% |
| Q2 2022 | $1,646,000 | -19.6% | 238,881 | +8.6% | 0.00% | 0.0% |
| Q1 2022 | $2,046,000 | -37.0% | 219,899 | -3.7% | 0.00% | 0.0% |
| Q4 2021 | $3,248,000 | -37.9% | 228,393 | +1.3% | 0.00% | -50.0% |
| Q3 2021 | $5,231,000 | +27.1% | 225,561 | +36.4% | 0.00% | +100.0% |
| Q2 2021 | $4,116,000 | -6.8% | 165,333 | +5.0% | 0.00% | -50.0% |
| Q1 2021 | $4,414,000 | -0.0% | 157,502 | +24.5% | 0.00% | 0.0% |
| Q4 2020 | $4,415,000 | -10.4% | 126,476 | +27.9% | 0.00% | 0.0% |
| Q3 2020 | $4,928,000 | – | 98,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
| Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
| Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
| RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
| Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
| Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
| HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
| Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
| HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
| Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |